Lexicon Pharmaceuticals, Inc.(NASDAQ:LXRX, a biopharmaceutical company focused on developing breakthrough treatments for human disease, updated its drug development progress and reported financial results for the three months. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) weekly performance is -12.90%. On last trading day company shares ended up $1.35. Analysts mean target price for the company is $2.83. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) distance from 50-day simple moving average (SMA50) is -19.54%.
Response Genetics, Inc.(NASDAQ:RGDX) a company focused on the development and sale of molecular diagnostic tests that help determine a patient’s response to cancer therapy, announced its consolidated financial results Response Genetics, Inc.(NASDAQ:RGDX) shares fell -22.41% in last trading session and ended the day on $0.900. RGDX Gross Margin is 47.00% and its return on assets is -54.90%. Response Genetics, Inc (NASDAQ:RGDX) quarterly performance is -34.78%.
Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) announced its financial results and operational highlights for the first quarter 2014. “During the quarter we reported additional data from our head and neck study which will help us with the design of our proposed registration study for discussion with regulators,” said Dr. Brad Thompson, President and CEO of Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY “We also took steps to improve our access to capital in order to support our clinical program, which continues to move ahead.” Oncolytics Biotech, Inc. (USA) NASDAQ:ONCY) shares moved down -6.99% in last trading session and was closed at $1.33, while trading in range of $1.31 – $1.48. Oncolytics Biotech, Inc. (USA)(NASDAQ:ONCY)year to date (YTD) performance is – -14.19%
MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. MacroGenics Inc (NASDAQ:MGNX) ended the last trading day at $18.45. Company weekly volatility is calculated as 7.92% and price to cash ratio as 4.37. MacroGenics Inc (NASDAQ:MGNX) showed a negative weekly performance of -5.34%.
Leave a Reply